References
- Devynck M A, Meyer P. Angiotensin receptors in vascular tissue. Am J Med 1976; 61: 758–67
- DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–23
- Moan A, Nordby G, Os I, Birkeland K, Kjeldsen S E. Relationship between hemorheological factors and insulin sensitivity in healthy, young men. Metabolism, in press
- Kjeldsen S E, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. Scand J Clin Invest 1982; 42: 217–23
- Christen Y, Waeber B, Nussberger J, et al. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal volunteers. Circulation 1991; 83: 1333–42
- Julius S, Gudbrandsson T, Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Pressure 1992; 1: 9–19
- Zimmerman B G. Adrenergic facilitation by angiotensin: does it serve a physiological function?. Clin Sci 1981; 60: 343–8
- Costa M, Majewski H. Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, beta-adrenoceptors and angiotensin II receptors. Br J Pharmacol 1988; 95: 993–1001
- Rump L C. Modulation of renal noradrenaline release by prejunctional receptors systems in vitro. Clin Exp Pharmacol Physiol 1987; 14: 423–8
- Gothert M. Regulation of noradrenaline release in human blood vessels. Pharmacol-Toxicol 1988; 63(Suppl 1)12–15
- Khairallah D A. Action of angiotensin in adrenergic nerve endings; inhibition of norepinephrine uptake. Fed Proc 1972; 31: 1351–7
- Rostrup M, Mundal H H, Westheim A, Eide I. Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress. J Hypertens 1991; 9: 159–66
- Ekeberg Ø, Ellertsen B B, Seeberg I, Kjeldsen S E. Plasma catecholamines in some airline passengers. Scand J Clin Invest 1989; 49: 183–8
- Sheu W H, Swislocki A L, Hoffman B, Chen Y D, Reaven G M. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens 1991; 4: 199–205, (3 Pt 1)
- Andronico G, Piazza G, Mangano M T, Mule G, Carone M B, Cerasola G. Nifedipine vs. enalapril in treatment of hypertensive patients with glucose intolerance. J Cardiovasc Pharm 1991; 10: S52–4
- Shionoiri H, Ueda S, Gotoh E, Ito T, Ogihara T. Glucose and lipid metabolism during long-term lisinopril therapy in hypertensive patients. J Cardiovasc Pharmacol 1990; 16: 905–9
- Paolisso G, Gambardella A, Verza M, D'Amore A, Sgambato S, Varricchio M. ACE inhibition improves insulin sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 1992; 6: 175–9
- Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide diuretics and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868–73
- Gans R OB, Bilo H JG, Nauta J P, Popp-Snijders C, Heie R J, Donker J M. The effect of angiotensin-1 converting enzyme inhibition on insulin action in healthy volunteers. Eur J Clin Invest 1991; 21: 527–33
- Ferrari P, Gianchino D, Weidmann P, et al. Unaltered insulin sensitivity during calcium channel blockade with amlodipine. Eur J Clin Pharmacol 1991; 41: 109–13
- Lithell H. Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 1991; 14: 203–9